LIFE - CIK 0001339970
aTYR PHARMA INC (LIFE) reported revenue of $190.00K for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $190.00K | -19.1% |
| FY 2024 | $235.00K | -33.4% |
| FY 2023 | $353.00K | -96.6% |
| FY 2022 | $10.39M | - |
| FY 2021 | $0.00 | -100.0% |
| FY 2020 | $10.46M | +2377.5% |
| FY 2019 | $422.00K | - |
aTYR PHARMA INC (LIFE) reported revenue of $190.00K for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, aTYR PHARMA INC's revenue declined from $422.00K to $190.00K.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.